Td Asset Management Inc Biogen Inc. Transaction History

Td Asset Management Inc

$107 Billion
Q3 2024

A detailed history of Td Asset Management Inc transactions in Biogen Inc. stock. As of the latest transaction made, Td Asset Management Inc holds 371,001 shares of BIIB stock, worth $64.5 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

371,001

Previous 380,788 2.57%

Holding current value

$64.5 Million

Previous $88.3 Million 18.53%

% of portfolio

0.07%

Previous 0.09%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	SELL	$189.07 - $236.8 $1.85 Million - $2.32 Million	-9,787 Reduced 2.57%	371,001 $71.9 Million
Q2 2024 Aug 02, 2024	BUY	$190.52 - $236.72 $2.58 Million - $3.21 Million	13,552 Added 3.69%	380,788 $88.3 Million
Q1 2024 May 08, 2024	SELL	$212.02 - $267.71 $4.82 Million - $6.09 Million	-22,748 Reduced 5.83%	367,236 $79.2 Million
Q4 2023 Feb 12, 2024	BUY	$222.59 - $267.94 $24.3 Million - $29.2 Million	108,956 Added 38.77%	389,984 $101 Million
Q3 2023 Oct 27, 2023	BUY	$253.3 - $285.89 $16.4 Million - $18.5 Million	64,844 Added 29.99%	281,028 $72.2 Million
Q2 2023 Aug 09, 2023	BUY	$275.25 - $318.06 $16.6 Million - $19.2 Million	60,325 Added 38.7%	216,184 $61.6 Million
Q1 2023 May 10, 2023	SELL	$256.56 - $292.34 $990,321 - $1.13 Million	-3,860 Reduced 2.42%	155,859 $43.3 Million
Q4 2022 Feb 06, 2023	SELL	$252.44 - $306.72 $1.19 Million - $1.45 Million	-4,732 Reduced 2.88%	159,719 $44.2 Million
Q3 2022 Nov 07, 2022	BUY	$194.69 - $268.46 $1.95 Million - $2.69 Million	10,013 Added 6.48%	164,451 $43.5 Million
Q2 2022 Aug 04, 2022	BUY	$187.54 - $223.02 $1.51 Million - $1.8 Million	8,049 Added 5.5%	154,438 $31.5 Million
Q1 2022 May 10, 2022	SELL	$193.77 - $244.14 $599,718 - $755,613	-3,095 Reduced 2.07%	146,389 $30.8 Million
Q4 2021 Feb 10, 2022	BUY	$223.92 - $287.77 $572,115 - $735,252	2,555 Added 1.74%	149,484 $35.9 Million
Q3 2021 Nov 09, 2021	BUY	$282.99 - $369.05 $7.17 Million - $9.34 Million	25,319 Added 20.82%	146,929 $41.6 Million
Q2 2021 Aug 11, 2021	SELL	$259.0 - $414.71 $2.96 Million - $4.74 Million	-11,425 Reduced 8.59%	121,610 $39.7 Million
Q1 2021 May 14, 2021	BUY	$242.95 - $284.63 $537,648 - $629,886	2,213 Added 1.69%	133,035 $37.2 Million
Q4 2020 Feb 16, 2021	BUY	$236.26 - $355.63 $3.97 Million - $5.98 Million	16,821 Added 14.76%	130,822 $32 Million
Q3 2020 Nov 10, 2020	BUY	$264.77 - $305.71 $6.36 Million - $7.35 Million	24,029 Added 26.71%	114,001 $32.3 Million
Q2 2020 Aug 13, 2020	SELL	$258.66 - $342.55 $9.1 Million - $12.1 Million	-35,196 Reduced 28.12%	89,972 $24.1 Million
Q1 2020 May 15, 2020	BUY	$268.85 - $341.04 $7.98 Million - $10.1 Million	29,669 Added 31.07%	125,168 $39.6 Million
Q4 2019 Feb 11, 2020	BUY	$220.06 - $304.07 $2.5 Million - $3.45 Million	11,356 Added 13.5%	95,499 $28.3 Million
Q3 2019 Nov 07, 2019	SELL	$217.44 - $243.88 $1.06 Million - $1.19 Million	-4,870 Reduced 5.47%	84,143 $19.6 Million
Q2 2019 Aug 01, 2019	BUY	$219.29 - $241.72 $341,434 - $376,358	1,557 Added 1.78%	89,013 $20.8 Million
Q1 2019 May 08, 2019	SELL	$216.71 - $338.96 $4.77 Million - $7.46 Million	-22,018 Reduced 20.11%	87,456 $20.7 Million
Q4 2018 Feb 01, 2019	SELL	$278.5 - $352.75 $988,118 - $1.25 Million	-3,548 Reduced 3.14%	109,474 $32.9 Million
Q3 2018 Nov 01, 2018	SELL	$293.51 - $383.83 $1.85 Million - $2.42 Million	-6,313 Reduced 5.29%	113,022 $39.9 Million
Q2 2018 Jul 31, 2018	SELL	$257.52 - $306.91 $9.63 Million - $11.5 Million	-37,379 Reduced 23.85%	119,335 $34.6 Million
Q1 2018 May 11, 2018	SELL	$260.13 - $367.91 $4.42 Million - $6.25 Million	-16,996 Reduced 9.78%	156,714 $42.9 Million
Q4 2017 Feb 02, 2018	SELL	$307.64 - $344.58 $4.03 Million - $4.52 Million	-13,115 Reduced 7.02%	173,710 $55.3 Million
Q3 2017 Nov 09, 2017	BUY	$281.15 - $329.69 $52.5 Million - $61.6 Million	186,825	186,825 $58.5 Million

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.

Account

Td Asset Management Inc Biogen Inc. Transaction History